Search
Search Results
##search.searchResults.foundPlural##
-
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2035PDF: 827HTML: 229 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2062PDF: 817HTML: 1148 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
974PDF: 576HTML: 2202Cover Letter: 201 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3336PDF: 966HTML: 2971 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
834PDF: 546HTML: 4026 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4062PDF: 1561HTML: 9194Untitled: 286Untitled: 193Untitled: 177Untitled: 171Untitled: 195Untitled: 350 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2689PDF: 973HTML: 3650 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2706PDF: 960HTML: 561 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
126PDF: 129HTML: 8 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7896PDF: 737HTML: 224 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2585PDF: 863HTML: 8918Efremov 1: 242Efremov 2: 207 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1904HTML: 1502PDF: 1125 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4891PDF: 2895HTML: 2320 -
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1712PDF: 1267HTML: 359 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2510HTML: 287PDF: 916 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1407PDF: 1038HTML: 374Suppl. Figure: 190Suppl. Tables: 213 -
WHAT ARE FUNGAL INFECTIONS?
4266PDF: 2438HTML: 27645de Pauw: 250 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1085PDF: 1195Suppl. Files: 574HTML: 94 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1574PDF: 900HTML: 992figures: 198table 1: 198table2: 195table3: 198 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1781PDF: 866HTML: 321 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1710PDF: 416HTML: 223 -
Spontaneous rupture of malarial spleen: report of two cases
836PDF: 413HTML: 2879jdoe, cover letter.doc: 184 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1381PDF: 1003HTML: 2010Cover letter: 206 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
905PDF: 508HTML: 212Suppl. Files: 335 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
999PDF: 1231HTML: 117







